<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01578161</url>
  </required_header>
  <id_info>
    <org_study_id>SNUBH_01</org_study_id>
    <nct_id>NCT01578161</nct_id>
  </id_info>
  <brief_title>The Effect of Dexmedetomidine on Emergence Agitation in Children Undergoing a Surgery Under Desflurane Anesthesia</brief_title>
  <official_title>The Effect of Dexmedetomidine on Emergence Agitation in Children Undergoing a Surgery Under Desflurane Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After genernal anesthesia using sevoflurane or desflurane, the investigators can observe many
      cases of agiation (over 80%) and despite of no report of long-term complication, agitation is
      a big issue in PACU for doctors and nurses. The investigators use dexmedetomidine for
      prevention of agiation of preschool aged children. The investigators expect single injection
      of dexmedetomidine lead to decrease postoperative agitation and pain without any complication
      like oculocardiac reflex requiring atopine for treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are four groups accoding to dosage of dexmedetomidine. Dexmedetomidine 0.25
      microg.kg(-1),(group D0.25), dexmedetomidine 0.5 microg.kg(-1),(Group D0.5), dexmedetomidine
      1 microg.kg(-1) (Group D 1) and normal saline(group P) is administered ivs. for 10mins when
      we are inducing each patient.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">April 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Agitation score</measure>
    <time_frame>30 mins after operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oculomotor reflex</measure>
    <time_frame>Intraoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Psychomotor Agitation</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine0.25</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexmedetomidine 0.25 microg.kg(-1),(Group D0.25) ivs. for 10min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine0.5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexmedetomidine 0.5 microg.kg(-1),(group D0.5) ivs. for 10min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine1.0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexmedetomidine 1 microg.kg(-1) ivs. for 10min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NormalSaline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline 10ml ivs. for 10min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>There are four groups accoding to dosage of dexmedetomidine. Dexmedetomidine 0.25 microg.kg(-1),(group D0.25), dexmedetomidine 0.5 microg.kg(-1),(Group D0.5), dexmedetomidine 1 microg.kg(-1) (Group D 1) and normal saline(group P) is administered ivs. for 10mins when we are inducing each patient.</description>
    <arm_group_label>Dexmedetomidine0.25</arm_group_label>
    <arm_group_label>Dexmedetomidine0.5</arm_group_label>
    <arm_group_label>Dexmedetomidine1.0</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% Normal Saline</intervention_name>
    <description>Placebo,Normal saline 10ml ivs. for 10min.</description>
    <arm_group_label>NormalSaline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Physical status classification of American Society of Anesthesiologist 1-2,

          -  Healthy, normal

          -  2-6 years old

          -  Elective operation

        Exclusion Criteria:

          -  Lack of consent

          -  Known adverse effects to dexmedetomidine, mental retardation

          -  Developmental delay, or neurological or psychiatric illness that may associate with
             agitation (cerebral palsy, seizure, etc)

          -  No cardiac disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AhYoung Oh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>INAE SONG</last_name>
    <phone>82-10-2609-2401</phone>
    <email>nodame1@naver.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, SEOUL NATIONAL UNIVERSITY BUNDANG HOSPITAL</name>
      <address>
        <city>SungNam-si</city>
        <state>Kyonggi do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SangHwan Do</last_name>
      <phone>82-31-787-7499</phone>
      <email>shdo@snubh.org</email>
    </contact>
    <investigator>
      <last_name>AhYoung Oh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2012</study_first_submitted>
  <study_first_submitted_qc>April 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2012</study_first_posted>
  <last_update_submitted>April 13, 2012</last_update_submitted>
  <last_update_submitted_qc>April 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Ah-Young Oh</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

